Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tejal A Patel

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Breast Cancer|May 26, 2010
Changes to adjuvant systemic therapy in breast cancer: a decade in reviewChristina A Saurel, Tejal A Patel, Edith A Perez
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 6, 2019
Enhanced dermatologic toxicity following concurrent treatment with palbociclib and radiation therapy: A case reportJay A Messer, Ekim Ekinci, Tejal A Patel, et al.
The Breast Journal|June 25, 2020
Metastatic triple-negative breast cancer: Established and emerging treatmentsAkshjot Puri, Tejaswini P Reddy, Tejal A Patel, et al.
The Oncologist|April 30, 2010
Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groupsTejal A Patel, Gerardo Colon-Otero, Celyne Bueno Hume, et al.
JCO Oncology Practice|March 8, 2021
Medical Complications and Prognostic Factors for Medically Unstable Conditions During Acute Inpatient Cancer RehabilitationJegy M Tennison, Brian C Fricke, Jack B Fu, et al.
Breast Cancer Research : BCR|May 1, 2015
Dual HER2 blockade: preclinical and clinical dataTejal A Patel, Bhuvanesh Dave, Angel A Rodriguez, et al.
Breast Cancer Research and Treatment|December 16, 2015
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patientsDiana H Liang, Joe E Ensor, Zhe-Bin Liu, et al.
Breast Cancer Research and Treatment|April 23, 2022
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastasesAkshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, et al.
Cancer Medicine|September 5, 2020
Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastasesKurt A Jaeckle, Jesse G Dixon, Stephen Keith Anderson, et al.
Cancer|August 30, 2016
Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methodsTejal A Patel, Mamta Puppala, Richard O Ogunti, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Breast Cancer|May 26, 2010
Changes to adjuvant systemic therapy in breast cancer: a decade in reviewChristina A Saurel, Tejal A Patel, Edith A Perez
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 6, 2019
Enhanced dermatologic toxicity following concurrent treatment with palbociclib and radiation therapy: A case reportJay A Messer, Ekim Ekinci, Tejal A Patel, et al.
The Breast Journal|June 25, 2020
Metastatic triple-negative breast cancer: Established and emerging treatmentsAkshjot Puri, Tejaswini P Reddy, Tejal A Patel, et al.
The Oncologist|April 30, 2010
Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groupsTejal A Patel, Gerardo Colon-Otero, Celyne Bueno Hume, et al.
JCO Oncology Practice|March 8, 2021
Medical Complications and Prognostic Factors for Medically Unstable Conditions During Acute Inpatient Cancer RehabilitationJegy M Tennison, Brian C Fricke, Jack B Fu, et al.
Breast Cancer Research : BCR|May 1, 2015
Dual HER2 blockade: preclinical and clinical dataTejal A Patel, Bhuvanesh Dave, Angel A Rodriguez, et al.
Breast Cancer Research and Treatment|December 16, 2015
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patientsDiana H Liang, Joe E Ensor, Zhe-Bin Liu, et al.
Breast Cancer Research and Treatment|April 23, 2022
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastasesAkshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, et al.
Cancer Medicine|September 5, 2020
Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastasesKurt A Jaeckle, Jesse G Dixon, Stephen Keith Anderson, et al.
Cancer|August 30, 2016
Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methodsTejal A Patel, Mamta Puppala, Richard O Ogunti, et al.
Pageof 2